Albert J. Robichaud
2013
In 2013, Albert J. Robichaud earned a total compensation of $302.5K as Chief Scientific Officer at Sage Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $2,500 |
|---|---|
| Salary | $300,000 |
| Total | $302,500 |
Robichaud received $300K in salary, accounting for 99% of the total pay in 2013.
Robichaud also received $2.5K in non-equity incentive plan.
Rankings
In 2013, Albert J. Robichaud's compensation ranked 10,815th out of 12,286 executives tracked by ExecPay. In other words, Robichaud earned more than 12.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,815 out of 12,286 | 12th |
Division Manufacturing | 4,037 out of 4,612 | 13th |
Major group Chemicals And Allied Products | 1,275 out of 1,462 | 13th |
Industry group Drugs | 1,009 out of 1,156 | 13th |
Industry Pharmaceutical Preparations | 786 out of 890 | 12th |
Source: SEC filing on April 17, 2015.
Robichaud's colleagues
We found two more compensation records of executives who worked with Albert J. Robichaud at Sage Therapeutics in 2013.
News
Sage Therapeutics CEO Barry Greene's 2021 pay jumps 469% to $59M
April 28, 2022
Sage Therapeutics CEO Jeffrey Jonas' 2020 pay falls 53% to $4.7M
April 29, 2021
Sage Therapeutics CEO Jeffrey Jonas' 2019 pay rises 1% to $9.9M
April 29, 2020
Sage Therapeutics CEO Jeffrey Jonas' 2018 pay jumps 71% to $9.8M
April 25, 2019